XOMA (US) LLC has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), Hong Kong and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are Mainline Biosciences, SILVER CREEK PHARMACEUTICALS INC and NOVELMED THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Hong Kong | 2 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Hungary | 1 | |
#6 | Mexico | 1 | |
#7 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Rubin Paul | 4 |
#2 | Horwitz Arnold | 3 |
#3 | Chen Gang | 3 |
#4 | Johnson Kirk W | 3 |
#5 | Roell Marina | 3 |
#6 | Masat Linda | 3 |
#7 | Haak-Frendscho Mary | 3 |
#8 | Corbin John | 2 |
#9 | Bhaskar Vinay | 2 |
#10 | Nath Rajneesh | 2 |
Publication | Filing date | Title |
---|---|---|
WO2016141111A1 | Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery | |
EP2794657A1 | Methods for treating acne |